Crypto Briefing August 11, 2026

Abbott launches AI-powered glucose tool Libre Assist, expanding its decade-long bet on algorithmic health insights

Abbott launches AI-powered glucose tool Libre Assist, expanding its decade-long bet on algorithmic health insights

Abbott's AI tool could revolutionize diabetes management by proactively influencing dietary choices, potentially improving patient outcomes.

The post Abbott launches AI-powered glucose tool Libre Assist, expanding its decade-long bet on algorithmic health insights appeared first on Crypto Briefing.

You might also like

Trump backs Nvidia CEO Jensen Huang after report …
Nov 01, 2026 Read
Anthropic’s IPO could make its founders worth up …
Nov 01, 2026 Read
National Grid buys Teesside land for what could b…
Nov 01, 2026 Read
Aramco takes 49% stake in Saudi AI company HUMAIN…
Nov 01, 2026 Read